# Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle

> **NCT00636519** · PHASE1 · COMPLETED · sponsor: **Emergent BioSolutions** · enrollment: 36 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** Botulism Antitoxin Bivalent (Equine) Types A and B
- **BIOLOGICAL:** Botulism Antitoxin Heptavalent (Equine) Types A-G

## Key facts

- **NCT ID:** NCT00636519
- **Lead sponsor:** Emergent BioSolutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00636519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00636519, "Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00636519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*